HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CVS Targets “Ingredients Of Concern” Under New Cosmetic Safety Policy

This article was originally published in The Rose Sheet

Executive Summary

CVS Caremark has pledged to replace "ingredients of concern" in its house-branded products when safer alternatives are available - and to prompt its manufacturer partners to do the same - under the company's new cosmetic safety policy

You may also be interested in...



CSC Report: Retailers Should Take Responsibility For Cosmetics Safety

If the federal government won’t keep potentially toxic cosmetics off the market, retailers should, NGO the Campaign for Safe Cosmetics says, scoring eight retailers on their ingredient screening programs and personal-care safety policies.

Resolution Urging Firms To Share Nanotech Policy Shows Investor Awareness

A shareholder resolution set before Avon and Colgate-Palmolive by the Calvert Group reflects the investment community's growing awareness of nanotechnology and its potential liabilities

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015433

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel